12月19日，港股三大指数高开高走，截至收盘，恒生指数上涨0.75%，恒生科技指数上涨1.12%，恒生国企指数上涨0.68%。 【导读】港股三大指数集体收涨 创新药、新能源汽车等涨幅靠前 具体来看，当日权重科技股集体上涨，腾讯、快手、网易、美团、百度均涨超1%。 板块方面，当日创新药概念股涨幅靠前，其中，映恩生物涨幅达9.29%，药明生物涨幅达4.4%。 | 代码 | 名称 | 现价 | 涨跌 | 涨跌幅 ▼ | | --- | --- | --- | --- | --- | | 9606 | 映恩生物-B | 336.600c | 28.600 | 9.29% | | 2269 | 药明生物 | 34.160c | 1.440 | 4.40% | | 6990 | 科伦博泰生物-B | 419.200c | 14.200 | 3.51% | | 1877 | 君实生物 | 23.240c | 0.760 | 3.38% | | 2162 | 康诺亚-B | 55.500c | 1.800 | 3.35% | | 2268 | 药明合联 | 70.000c | 2.050 | 3.02% | | 1530 | ...

中国经济网北京12月19日讯 君实生物（688180.SH）昨日晚间披露《关于持股5%以上股东减持股 份计划的公告》。 根据公告，上海檀英投资合伙企业（有限合伙）（以下简称"上海檀英"）计划通过大宗交易的方式 减持其持有的公司股份数量不超过20,533,797股，减持比例不超过公司总股本的2%。减持期间为2026年 1月13日至2026年4月10日。 截至公告披露日，上海檀英持有君实生物股份59,459,326股，股份性质为A股，占公司总股本的 5.7914%。上述股份为公司首次公开发行股票并在上海证券交易所科创板上市前取得的股份，且已于 2021年7月15日起解除限售并上市流通。 上海檀英为公司第三大股东。上述减持主体存在一致行动人：上海檀英的执行事务合伙人为上海正 心谷投资管理有限公司，实际控制人为林利军，上海檀英持有公司股份的性质为A股。Loyal Valley Capital Advantage Fund II LP及LVC Renaissance Fund LP均为林利军实际控制的合伙企业，其持有公司股 份的性质为H股。上海檀英及其一致行动人合计持有公司股份75,217,999股，占公司总股本的7. ...

Market Overview - The US CPI annual rate decline has led to a rise in US stocks, boosting risk market sentiment [1] - The Hang Seng Index opened higher and closed up 0.75%, with the Hang Seng China Enterprises Index and Hang Seng Tech Index rising by 0.68% and 1.12% respectively [1][2] Sector Performance - Major technology stocks saw collective gains, with Tencent up 1.49%, Kuaishou up 1.45%, and Meituan up 1.28% [4] - Pharmaceutical stocks were active, with WuXi AppTec and other related stocks rising [2] - Gaming stocks continued to rise, with MGM China leading with a 6.6% increase [2][5] - AI-driven demand boosted optical fiber and cable stocks, with Yangtze Optical Fiber rising 12% [2] - Automotive, wind power, education, photovoltaic, insurance, and Apple-related stocks also experienced gains [2] Notable Stock Movements - Xpeng Motors rose 7.65%, Horizon Robotics up 7.04%, and Li Auto up 3.81% [4][10] - Electronic cigarette stocks saw significant increases, with China Tobacco Hong Kong up 6.68% [5] - Chinese brokerage stocks rose, with China International Capital Corporation up over 4% [7] - Intelligent driving concept stocks surged, with Youjia Innovation up 31.22% [8] Weak Performers - Heavy machinery stocks faced declines, with China National Heavy Duty Truck Group down over 6% [13] - Gold and precious metal stocks were weak, with several companies experiencing declines of over 2% [16] - Oil stocks also fell, with China Petroleum & Chemical Corporation down 1.52% [15] Capital Flows - Southbound funds recorded a net purchase of HKD 3.371 billion, with net selling from Shanghai-Hong Kong Stock Connect and net buying from Shenzhen-Hong Kong Stock Connect [18] Market Outlook - CITIC Securities suggests that after a strong performance in September, Hong Kong stocks are undergoing a mid-term adjustment, with quality assets entering a high-value zone [18]

证券日报网讯 12月18日晚间，君实生物发布公告称，截至本公告披露日，上海檀英投资合伙企业（有 限合伙）（以下简称"上海檀英"）持有上海君实生物医药科技股份有限公司（以下简称"公司"或"君实 生物"）股份59，459，326股，股份性质为A股，占公司总股本的5.7914%。上海檀英长期看好公司的发 展，因基金期限与流动性资金安排原因，计划通过大宗交易的方式减持其持有的公司股份数量不超过 20，533，797股，减持比例不超过公司总股本的2%。上海檀英为在中国证券投资基金业协会备案的私 募基金，已成功申请适用《上市公司创业投资基金股东减持股份的特别规定》和《上海证券交易所上市 公司创业投资基金股东减持股份实施细则》的减持政策：拟通过大宗交易方式减持的，在任意连续60日 内减持股份的总数不超过公司总股本的2%，自本公告披露之日起15个交易日后的三个月内进行。 （编辑 姚尧） ...

Group 1 - The Hong Kong stock market indices rose significantly on December 19, with the biopharmaceutical sector leading the gains [1] - The Hong Kong Innovative Drug ETF (159567) increased by 2.31%, with a trading volume exceeding 656 million yuan and a turnover rate of over 7.9%, indicating active trading [1] - Notable individual stocks included InnoCare Pharma-B rising over 8%, Lepu Biopharma-B increasing over 5%, and 3SBio rising over 4% [1] Group 2 - Two Phase III clinical study results led by a Chinese research team on Marsduo peptide were published in the British journal Nature, focusing on its use in type 2 diabetes patients [1] - The studies, DREAMS-1 and DREAMS-2, were based on clinical data from Chinese patients and involved collaboration with leading experts and institutions in the field [1] - According to Dongfang Caifu Securities, China's innovative drug companies are entering a period of intensive pipeline harvest, with the market expected to exceed 400 billion yuan in 2024 [1] Group 3 - The number of approved domestic innovative drugs during the "14th Five-Year Plan" period is projected to be 113, which is 2.8 times that of the "13th Five-Year Plan" period [1] - The total amount of innovative drug License-out projects has reached a new record, with preclinical projects accounting for 68%, indicating growing global recognition of Chinese innovations [1] Group 4 - The Hong Kong Innovative Drug ETF closely tracks the National Index for Hong Kong Stock Connect Innovative Drugs, featuring leading stocks such as BeiGene, Innovent Biologics, and 3SBio [2] - The ETF includes several AI-driven pharmaceutical leaders, suggesting a high proportion of innovative drug companies, which may exhibit high elasticity as the AI-enabled innovative drug market expands [2]

Group 1 - Western Mining's wholly-owned subsidiary, Golmud West Mining Resources, has obtained a mining license for the iron polymetallic mine in the Itun Chahan West C5 anomaly area, which is crucial for the sustainable development of the iron resource sector [1] - Zhongwei Company is planning to acquire controlling stakes in Hangzhou Zhonggui through a share issuance, with the asset valuation and pricing yet to be determined; trading will be suspended for up to 10 trading days [2] - Nandu Power's controlling shareholder has terminated plans for a change in control after failing to reach consensus with the transaction parties, leading to the resumption of trading [3] Group 2 - Shikong Technology has won a smart cultural tourism integration project with a bid amount of 141 million yuan [4] - Ruichen Environmental Protection's shareholder plans to reduce their stake by up to 3%, amounting to a maximum of 214,900 shares [5] - Heimu Dan's wholly-owned subsidiary has successfully acquired land use rights for a total price of 677 million yuan [6] Group 3 - Lihu Lake's shareholder intends to reduce their stake by up to 2.98%, equating to a maximum of 6.47 million shares [7] - Zhongfutong has received a winning notification for two procurement projects from China Mobile, with estimated amounts of 411 million yuan and 162 million yuan [8] - Hongda Electronics' associate company, Jiangsu Zhanxin, has had its application for listing on the Growth Enterprise Market accepted [10] Group 4 - Hefei Construction's controlling subsidiary has acquired land use rights for an industrial site in Hefei for 1.6933 million yuan [11] - Qibin Group's subsidiary plans to invest 600 million yuan to establish a new energy company in Shenzhen [12] - Junshi Biological's shareholder plans to reduce their stake by up to 2%, amounting to a maximum of 20.53 million shares [13] Group 5 - Huahai Chengke's shareholder intends to reduce their stake by up to 1%, equating to a maximum of 960,100 shares [14] - Boshuo Technology's directors and senior management plan to reduce their holdings by up to 18,300 shares [15] - Huayi Group's subsidiary plans to sell two warehouses for a total of approximately 3.265 million USD, with expected profit increases [16] Group 6 - Puna shares have acquired a 15.28% stake in Xinjiang Qinxiong for 10 million yuan, increasing their ownership from 52.49% to 67.77% [17] - Dongwei Semiconductor plans to jointly invest in Suzhou Denglin Technology, with a total transaction amount of 10 million yuan [18][19] - Chengda Biological is adjusting the internal investment structure of some fundraising projects, including terminating the development of a specific vaccine [20] Group 7 - Guoao Technology's former controlling shareholder has been sentenced to six years in prison for market manipulation, but the company's operations remain normal [21] - Yinglian Co. plans to establish a wholly-owned subsidiary in Russia with a registered capital of 500,000 rubles [22] - Anlian Ruishi's chairman plans to reduce their stake by up to 670,000 shares [23] Group 8 - Baipusais plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [24] - Dazhong Mining's shareholders and chairman plan to reduce their stakes by a total of up to 1.44% [25] - Guoxing Optoelectronics intends to transfer 49% of its wholly-owned subsidiary's equity to a strategic investor for 35,900 yuan [26] Group 9 - Aishida plans to invest up to 200 million yuan in low-risk financial products using idle funds [27] - CIMC Group's subsidiary intends to purchase residential properties for 293 million yuan to meet employee housing needs [28] - Guandun Quantum announced the unfortunate passing of its chairman, who held no shares in the company [30] Group 10 - Zhenjiang's controlling shareholders have committed not to reduce their stakes for six months starting from December 19, 2025 [31] - Haitian Flavor Industry has announced a shareholder return plan, committing to a cash dividend ratio of no less than 80% for the next three years [32] - Xusheng Group's controlling shareholder is planning a change in control, leading to a temporary suspension of trading [33] Group 11 - Tianfeng Securities plans to extend a 4 billion yuan subordinated debt for one year and adjust the interest rate from 5% to 4% [34] - Shandong Highway intends to make a provision for impairment of long-term equity investments in Dongxing Securities, estimated at approximately 690 million yuan [35] - Yidong Electronics' controlling shareholder and related parties plan to reduce their holdings by 2% [36] Group 12 - Ningbo Construction's subsidiary has won a project bid worth 747 million yuan for infrastructure enhancement in Fenghua [37]

Capital Market Developments - The China Securities Regulatory Commission is advancing the "14th Five-Year Plan" for the capital market, focusing on enhancing the market's inclusivity and attractiveness to quality enterprises in new production sectors [2] - Morgan Stanley's China equity strategy head forecasts that the MSCI China Index, CSI 300 Index, and MSCI Hong Kong Index will reach target levels of 100 points, 5200 points, and 16000 points respectively, indicating potential double-digit growth [2] - Hong Kong's capital market is experiencing a surge in IPOs, with several companies including Yingxi Intelligent, Wuyi Vision, and others launching public offerings, set to list on December 30 [2] Industry Highlights - The State Council has issued guidelines to strengthen regulation of the e-cigarette industry, aiming to combat illegal production and sales of products similar to tobacco [4] - Trump Media Technology Group is set to merge with nuclear fusion company TAE in an all-stock transaction, leading to a significant rise in Trump Media's stock [4] Company Updates - ByteDance's AI model, Doubao, has achieved a daily usage rate exceeding 50 trillion calls, while Microsoft is reportedly collaborating with Kimi to automate Office products in response to local competition [6] - Haidilao has announced a shareholder return plan, committing to a cash dividend payout ratio of no less than 80% over the next three years [6] - Shandong High-Speed plans to recognize a long-term investment impairment of approximately 690 million yuan related to Dongxing Securities, which is expected to reduce the company's total profit for 2025 by the same amount [6] - Guoao Technology's former actual controller has been sentenced to six years in prison for manipulating the securities market [8]

Market News - In November, the US CPI inflation unexpectedly slowed, with a year-on-year increase of 2.7%, lower than the expected 3.1%. The core CPI rose by 2.6%, against an expectation of 3% [1] - Major US stock indices rose collectively, with the Dow Jones up 0.14%, Nasdaq gaining over 310 points (1.38%), and S&P 500 increasing by 0.79%. Notable tech stocks like Tesla, Amazon, and Facebook saw significant gains [1] Industry Insights - At the FORCE conference, ByteDance's Volcano Engine announced the release of the Doubao model 1.8 and the Seedance 1.5pro audio-video creation model. The Doubao model's daily token usage exceeded 50 trillion, growing over 10 times year-on-year, with over 100 enterprise clients [3][4] - Micron Technology reported adjusted revenue of $13.64 billion for Q1 FY2026, exceeding analyst expectations of $12.95 billion. The company anticipates Q2 revenue between $18.3 billion and $19.1 billion, significantly higher than the expected $14.38 billion [5] - The hyperspectral remote sensing satellite application platform developed by Zhongke Xiguang completed asset certification, valued at approximately 27 million yuan, marking a significant step in the commercialization of satellite data [6][7] - The satellite internet industry is projected to reach 200-400 billion yuan by 2030, with a compound annual growth rate of 10%-28%, indicating a shift towards large-scale applications in satellite communication [7] Stock Movements - Several companies announced plans for share reductions, including Boshuo Technology, Huahai Chengke, Junshi Biosciences, and others, with reductions ranging from 0.011% to 3% of their total share capital [8][9]

盘前要闻 1、事关资本市场，证监会发声!吸引更多新质生产力领域优质企业上市 类型：宏观 情绪影响：正面 12月18日，证监会主席吴清主持召开资本市场"十五五"规划专家座谈会。其中指出，进一步提高发行上 市交易制度的包容性、适应性，吸引更多新质生产力领域优质企业上市;扩大耐心资本、长期资本和战 略资本供给等。行业方面，强调推动完善人工智能在资本市场应用的治理和监管。 2、特朗普商业帝国再扩张!DJT并购TAE转型为核聚变能源公司 类型：行业 情绪影响：正面 特朗普媒体与科技集团(DJT)与核聚变能源公司TAE达成全股票交易合并，交易总价值超过60亿美元， 合并后公司计划于2026年建设全球首座公用事业规模聚变发电厂。DJT股价大幅飙升涨超40%。两家公 司称，核聚变发电站有望提供充裕且稳定的电力，助力美国在人工智能革命中占据优势地位。 3、提振消费政策频出!商务部在北京等50个城市开展消费"三新"试点工作 类型：行业 情绪影响：正面 近日，商务部办公厅、财政部办公厅印发《关于做好消费新业态新模式新场景试点有关工作的通知》， 在北京等50个城市开展消费新业态新模式新场景试点。近期消费利好政策频出，机构表示，消费领 ...

Group 1: Capital Market Developments - Wu Qing emphasized the need to enhance the inclusiveness and attractiveness of the capital market to better serve high-quality economic development and modernization [1] - The China Securities Regulatory Commission (CSRC) is committed to implementing the "14th Five-Year Plan" for the capital market, focusing on risk prevention, strong regulation, and promoting high-quality development [1] Group 2: Economic Indicators - The U.S. November CPI increased by 2.7%, lower than the expected 3.1%, while the core CPI rose by 2.6%, against an expectation of 3% [2] - Initial jobless claims in the U.S. were reported at 224,000, slightly below the forecast of 225,000 [2] - Following the data release, the likelihood of a Federal Reserve rate cut in January rose from 26.6% to 28.8% [2][6] Group 3: IPO and Market Activities - Shenzhen Dapu Microelectronics is set to undergo an IPO review on December 25, marking the first IPO of an unprofitable company on the ChiNext board [3] - The company reported cumulative losses of 1.566 billion yuan from 2022 to the first half of 2025 [3] Group 4: Regulatory Updates - The State-owned Assets Supervision and Administration Commission (SASAC) has refined the accountability system for central enterprises, introducing compliance exemption clauses for due diligence in investment [5] - The State Administration for Market Regulation is focusing on optimizing the business environment and addressing "involution" competition to promote healthy market order [8] Group 5: Corporate Announcements - Guo An Quantum's chairman, Lv Pin, passed away at the age of 46, which may impact the company's strategic direction [22] - Feilong Co., Ltd. experienced a stock price surge of 29.02% following the announcement of a share reduction by its controlling shareholder [18] - Puyang Co. acquired a 15.28% stake in Xinjiang Qinxiong for 10 million yuan, increasing its ownership from 52.49% to 67.77% [20] - Chicheng Co. plans to invest up to 80 million yuan of idle funds in short-term cash management products to enhance capital efficiency [21] - Master Kong's CEO, Chen Yingrang, will retire, with Wei Hongcheng, the founder's son, taking over as CEO starting January 1, 2026 [22]